Navigation Links
International Federation of Sports Medicine Selects Celadrin(R) Topical Cream as it's First and Only Official Joint and Muscle Topical Cream
Date:2/25/2008

SAN DIEGO, Feb. 25 /PRNewswire/ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX), announced today that the International Federation of Sports Medicine (FIMS) and its Executive Committee has selected Celadrin(R) Topical Cream as its Official Pain Relieving Cream. FIMS's goal since 1928 was to provide the best medical care for the athletes of the summer and winter Olympic Games. Now it has expanded its goal to provide the most advanced knowledge and technologies in sports medicine for world class athletes and exercise enthusiasts.

Commenting on the recommendation, Mr. William Spencer, Imagenetix's Chief Executive Officer said, "We are extremely excited to have our Inflame Away(R)- Celadrin(R) selected by this World Class organization. FIMS consists of national associations of top sports medicine physicians, specialists and researchers and their endorsement is indicative of the strong science surrounding the product and the effective results the product has produced in athletes. The highly compelling scientific data from clinical trials in the area of pain management and reduction of inflammation was key to their recommendation."

Celadrin(R) has been endorsed by FIMS as the official pain relieving cream for a period encompassing the years 2008 until 2012. Celadrin(R) will maintain this exclusive and prestigious association throughout this athletic cycle.

Mr. Spencer added, "We believe this endorsement will be instrumental in our retail launch of our branded product and will be the cornerstone of an advertising program utilizing testimonials of athletes alike that have used and endorse the product."

Dr. Walter Frontera, the president of FIMS, stated that "FIMS is very impressed with the scientifically validated Celadrin(R) Topical Pain Cream. After reviewing the scientific attributes of Celadrin(R) Topical Pain Cream, FIMS is convinced of its efficacy for the treatment of soft tissue injuries that may interfere with sports performance."

About FIMS

The Federation Internationale de Medecine du Sports (FIMS)/International Federation of Sports Medicine is an international organization comprised of individual members, national associations, and multinational groups, with a common involvement with sports medicine on all continents. FIMS aims primarily to promote the study and development of sports medicine throughout the world, to assist athletes in achieving optimal performance, and to enhance health through the practice of exercise and physical activity in the general population. http://www.fims.org.

About Imagenetix

Based in San Diego, California, Imagenetix, (OTC Bulletin Board: IAGX) is an innovator of scientifically tested, natural-based, proprietary bioceutical products developed to enhance human health on a global basis. Imagenetix develops, formulates and private-labels propriety over-the-counter topical creams, skincare products and nutritional supplements to be marketed globally through multiple channels of distribution. In addition, the company develops patentable compounds for entering into licensing agreements with pharmaceutical partners. Imagenetix is the creator of Inflame Away(R)- Celadrin(R), which has been clinically tested to relieve osteoarthritis pain and significantly improve joint health. For more information on Celadrin(R), please visit, http://www.celadrin.com.

This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements are subject to risks and uncertainties that could cause actual results to vary materially from those projected in the forward-looking statements. The company may experience significant fluctuations in future operating results due to a number of economic, competitive, and other factors, including, among other things, the size and timing of customer contracts, new or increased competition, changes in market demand, and seasonality of purchases of the company's products and services. These factors and others could cause operating results to vary significantly from those in prior periods and those projected in forward-looking statements. Additional information with respect to these and other factors, which could materially affect the company and its operations, are included in certain forms the company has filed and will periodically file with the Securities Exchange Commission.


'/>"/>
SOURCE Imagenetix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. 2008 International Stroke Conference Highlights Impact of Merci Retrieval System
2. Pezcoller Foundation-AACR International Award for Cancer Research recognizes Axel Ullrich
3. Logistical information for the 2008 International Stroke Conference
4. China Dongsheng International Announces Fiscal Year 2008 Second Quarter Financial Results
5. ASA International Stroke Conference 2008
6. DATATRAK International Management to Host Conference Call on February 26, 2008 to Discuss Fourth Quarter and Full Year Operating Results for 2007
7. ORBIS Internationals Flying Eye Hospital Returns to Myanmar
8. Global Med Technologies(R), Inc. Adds Internationally Renowned NewYork- Presbyterian Hospital to Client List
9. Tahitian Noni International Expands HIRO(TM) Beverage Line With Super Fruits Sparkling Black Currant
10. Service Corporation International Declares Quarterly Cash Dividend
11. Healthy Coffee International, Inc. Establishes Healthy Coffee USA, Inc. as Its Marketing Arm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
Breaking Medicine Technology: